# Tomihisa Kamada

> Tomihisa Kamada is a seed investor at Axelspace Holdings backing Fitness. See 3 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: Angel Investor
- Fund: Axelspace Holdings
- Location: Tokyo, Japan
- Total investments: 3
- Last investment: Jun 2019
- Lead investor: 0%
- Last updated: Sep 2026
- Facebook: https://www.facebook.com/checkpoint/block/

Tomihisa Kamada is a seed investor at Axelspace Holdings in Tokyo focused on Fitness and Medical. Dr. Kamada earned his Ph.D. at the University of Tokyo. In 1984, he pursued his journey to establish his own business that focused on information appliances and mobile software, namely ACCESS Co., Ltd.. With great success, the company entered the Tokyo Stock Exchange Mothers Market in 2001. He left ACCESS Co., Ltd. in 2011, and founded TomyK Ltd.in 2012 where he supports startups possessing revolutionary business ideas that revitalize the Japanese economy.

## Contacts

5 contacts available for Tomihisa Kamada: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/tomihisa-kamada?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Fitness | 2 | 67% |
| Medical | 2 | 67% |
| Genetics | 1 | 33% |
| Wellness | 1 | 33% |
| Health Care | 1 | 33% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Angel | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SmarTrial | Activaid owns and operates a social data platform for patients with inflammatory bowel disease. It allows patients to support and exchange information within the patient community with the same disease; provide information necessary for new drug development and matching to clinical trials that suits them; and improve medical treatment. YasuakiHasebe founded Activaid in 2018. It has its headquarters in Tokyo in Japan. |  | Angel | Jun 13, 2019 |  |
| MinD in a Device | MinD in a Device Co., Ltd. is a university-launched venture that aims to port human consciousness to devices (machines and computers) in the medium to long term based on long-term research results on consciousness. As the first step toward realization, we will evolve and deepen the "generation model" considered to be the source ofconsciousness, and promote the development of next-generation AI and social implementation. |  | Seed | Mar 25, 2019 |  |
| Genomelink | Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others. | $7.1M | Seed | Aug 22, 2017 |  |

3 of 3 investments shown.

## Co-investors
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 1 deal together
- [Japanese Organization for Medical Device Development](https://shizune.co/investors/profile/japanese-organization-for-medical-device-development) — VC Fund, 1 deal together
- [M3.com](https://shizune.co/investors/profile/m3-com) — VC Fund, 1 deal together

## About Axelspace Holdings

VC Fund · Nihombashi-hamacho, Japan

Axelspace is a startup company developing businesses in the microsatellite field. Axelspace plans to construct a monitoring platform to cover the entire globe on a daily basis at extremely low cost.

5 contacts available at Axelspace Holdings.

| Name | Title | Profile |
| --- | --- | --- |
| Kamata Tomihisa | External Director | https://shizune.co/investors/profile/kamata-tomihisa |
| Masaru Murai | Auditor | — |
| Naoki Miyashita | Director & CTO | — |
| Takashi Eishima | Senior Fellow | — |
| Tomihisa Kamada | External Director | — |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Tomihisa Kamada invest in?

Tomihisa Kamada invests primarily in Fitness, Medical and Genetics startups, most often at Seed and Angel stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Tomihisa Kamada?

Public channels for Tomihisa Kamada include Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Tomihisa Kamada last invest?

The most recent investment recorded for Tomihisa Kamada closed in Jun 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co